InsiderClue
Insiders · Profile

REED JOHN C

EVP, Innovative Medicine, R&D at Johnson & Johnson · Director at IONIS PHARMACEUTICALS. Filing since 22 Jun 2012. CIK 0001181561

JNJ Johnson & Johnson EVP, Innovative Medicine, R&D · 3 trades IONS IONIS PHARMACEUTICALS INC Director · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
JNJ Johnson & Johnson
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold at will
53,931
$13.11M
83.5%
JNJ Johnson & Johnson
17 Oct 2025
EVP, Innovative Medicine, R&D
Sold at will
21,721
$4.19M
67.1%
JNJ Johnson & Johnson
17 Jul 2025
EVP, Innovative Medicine, R&D
Sold at will
19,137
$3.13M
64.2%
IONS IONIS PHARMACEUTICALS INC
6 Sep 2012
Director
Sold, plan not stated
4,900
$74.36K
100%
IONS IONIS PHARMACEUTICALS INC
4 Sep 2012
Director
Sold, plan not stated
5,100
$77.37K
100%
IONS IONIS PHARMACEUTICALS INC
9 Jul 2012
Director
Sold, plan not stated
10,000
$139.90K
100%
IONS IONIS PHARMACEUTICALS INC
22 Jun 2012
Director
Sold, plan not stated
10,000
$110.60K
100%
7 decisions on file.